Gynecor™ Introduces Novel Test to Detect Uterine Cancer

GLEN ALLEN, Va.--(BUSINESS WIRE)--GynecorTM is pleased to introduce a new test to detect endometrial cancer with minimal discomfort for the patient. The new TruTestTM uses a gentle brushing technique to collect a uterine biopsy from the patient in the physicians’ office in less than one minute. The specimen is then returned to GynecorTM, the diagnostic laboratory that processes the sample and reports on the presence or absence of uterine cancer, often within 24 hours.
MORE ON THIS TOPIC